A series of recent studies in mice and rats has mapped specific brain circuits that appear to drive chronic pain, identifying ...

The State of Texas will launch its own program to research a psychoactive drug called ibogaine after it was unable to find a ...

Algernon Health Inc. (the 'Company” or 'Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that it intends to change its corporate name from 'Algernon ...

Cortisol can disrupt the brain’s ability to manage stress, such as provoked by traumatic social media content—and its impact ...

The finalists for the third annual Chancellor’s Innovation Awards at University of California San Diego represent a new ...

BRAINBox Solutions today provided an update on the clinical, development, and corporate progress in its BRAINBox TBI diagnostic/prognostic test program. The BRAINBox tests for concussion (also known ...

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Transcend Therapeutics, Inc. (Transcend) announce that the two companies entered ...

The future king, 43, was moved to write to the American athlete after she suffered a broken leg 13 seconds into the women's ...

A fall on the head, a blow to the skull, or a road traffic accident—the causes of traumatic brain injury are diverse, but the ...

Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, announced that, as previously ...

Parkinson's disease is a neurodegenerative disorder characterized by the progressive loss of dopamine-producing nerve cells in the brain, leading to motor slowing, gait and balance problems ...